Company: ATRA
Filing Date: 2025-05-23
Form Type: 3
Source: 0001104659-25-052406
Chunk: 1

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-05-23
Form: 3
Chunk 1
---
 |                   |                          |     |     |   |
| Pre-Funded Warrants to Purchase Common Stock |                                                     [F1] | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F1] - [F1]       | Common Stock - 3,412,843 | N/A | N/A | I |
| Cash-settled Swaps                           |                                                  $809.86 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F3,F4,F5] - [F4] | Common Stock - 4,103     | N/A | N/A | I |
| Cash-settled Swaps                           |                                                    $9.31 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F3,F4,F5] - [F4] | Common Stock - 4,872     | N/A | N/A | I |

Remarks:

Mr. Nachi Subramanian, a member of the board of directors of the Issuer and a managing director of Redmile, was elected to the board of the Issuer as a representative of Redmile and its affiliates. As a result, the Reporting Persons are directors by deputization for purposes of Section 16 of the Securities Exchange Act of 1934, as amended.

| ** Signature of Reporting Person                                
 /s/ By: /s/ Jeremy Green, Managing Member of Redmile Group, LLC | Date       
 05/23/2025 |

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. 
 Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.